{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/gallstones/management/asymptomatic-gallstones/","result":{"pageContext":{"chapter":{"id":"2acb7d51-f695-56e8-ab80-27b2cd747cb6","slug":"asymptomatic-gallstones","fullItemName":"Scenario: Asymptomatic gallstones","depth":2,"htmlHeader":"<!-- begin field 4ef9fa79-0aac-4342-9564-82a48c23f884 --><h2>Scenario: Management of people with asymptomatic gallstones</h2><!-- end field 4ef9fa79-0aac-4342-9564-82a48c23f884 -->","summary":"Covers the diagnosis and referral of people with asymptomatic gallstones.","htmlStringContent":"<!-- begin item fc29f76c-471a-408d-8152-c2c4459c7022 --><!-- begin field 2cb19b40-0287-4463-8826-acbc015762b9 --><p>From age 18 years onwards.</p><!-- end field 2cb19b40-0287-4463-8826-acbc015762b9 --><!-- end item fc29f76c-471a-408d-8152-c2c4459c7022 -->","topic":{"id":"b39f129d-317e-5f6f-8d43-a4b23ddcb2e8","topicId":"b66a5697-882a-4143-a0c6-32b03657c794","topicName":"Gallstones","slug":"gallstones","lastRevised":"Last revised in June 2019","chapters":[{"id":"06a059af-2d68-5ae7-8e88-57f00c6cdb2f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e0f409fd-998f-5b21-9f3a-5f11ad52d70f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9db03e94-e4f9-5d18-bd20-c911b8c565e7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"83aa8167-37ee-5580-b667-eeed0c3c6864","slug":"changes","fullItemName":"Changes"},{"id":"e4b85e87-e2a9-57ce-846e-56d02c965e49","slug":"update","fullItemName":"Update"}]},{"id":"646754ea-ab1a-5659-bc5e-90394d1f97b8","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c619902d-f978-51b5-809a-8b8236aefac7","slug":"goals","fullItemName":"Goals"},{"id":"5d3a306f-2228-5592-8a4e-035ea7b6849c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6070d034-6424-5a50-bc71-08f38595f3f0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5a16b326-1085-51b8-ae96-a5dc6abc6057","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"23d93c7f-b7c8-5cb8-9b89-a830fd26ebeb","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6ba0df39-ebe7-56ba-9f99-dac753d01334","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8bd75f7e-fefc-54b5-be6f-d430c0236d31","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e3ba4382-5956-5166-bb69-18323a48c241","slug":"definition","fullItemName":"Definition"},{"id":"ffdb00d1-09f5-52b3-8e1f-88dce54b7b9d","slug":"causes-types","fullItemName":"Causes/types"},{"id":"8f6e2df0-5461-54c6-96d4-664988a603e2","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e0e39604-8c24-5a55-938c-3ae59365b54b","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"2d54fa2b-9f4f-5ef5-a029-42b767680e23","slug":"complications","fullItemName":"Complications"},{"id":"0cd640a4-d769-5923-bcbc-bef19928e61d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"0dfd6ada-c9e0-57bf-9473-cf3dfde76649","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4636036f-8d31-5148-b8a3-e73d1fec45b3","slug":"suspecting-gallstone-disease","fullItemName":"Suspecting gallstone disease"},{"id":"6a53b54e-76cd-5728-8c33-5775a0b39236","slug":"diagnostic-tests","fullItemName":"Diagnostic tests"},{"id":"dc2e121d-bdd5-5b92-a500-44de035636e8","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b39075f6-e604-5be9-8799-2c4c7d3288eb","fullItemName":"Management","slug":"management","subChapters":[{"id":"2acb7d51-f695-56e8-ab80-27b2cd747cb6","slug":"asymptomatic-gallstones","fullItemName":"Scenario: Asymptomatic gallstones"},{"id":"3bb7061b-d3ce-5dd1-af52-fccd62ee31c5","slug":"symptomatic-gallstones","fullItemName":"Scenario: Symptomatic gallstones"}]},{"id":"67ca9e67-11b3-5a78-a940-b450ce4b9559","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9609ca4c-a24b-518e-a4cb-33214f12bb60","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f66c462e-1d3c-52cb-bbb9-fd85631939e0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"2cafaed8-846c-5425-9e95-c25fced4b765","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6a20e318-0a3a-5ca9-af4d-e296bbd19df0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a604fa80-6d52-50ed-baaf-06b4b1fd604c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"694e5ce7-1548-5f3a-adc1-f68b88fdb1a7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ed17b391-ccf9-50d8-9ef2-cb8923c89ba7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b39075f6-e604-5be9-8799-2c4c7d3288eb","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"f0dbfa9b-85e2-5a65-810b-f3900fdf6f00","slug":"asymptomatic-gallstones","fullItemName":"Asymptomatic gallstones","depth":3,"htmlHeader":"<!-- begin field cf88b96d-ac34-4222-b1cc-50107103b9a5 --><h3>How do I manage a person with asymptomatic gallstones?</h3><!-- end field cf88b96d-ac34-4222-b1cc-50107103b9a5 -->","summary":null,"htmlStringContent":"<!-- begin item fc311a4a-7674-4853-8ac6-d6b9152c118c --><!-- begin field 40d6d47f-407e-4d86-823e-0c70c062ac65 --><ul><li><strong>For a person with asymptomatic gallstones found in a normal gallbladder and normal biliary tree: </strong><ul><li>Reassure them that they do not need treatment unless they develop symptoms. </li><li>Explain that asymptomatic gallstones are very common. </li><li>Prophylactic treatments aimed at preventing future complications are not recommended (such as prophylactic cholecystectomy) as the risk of complications from surgical treatment outweighs the potential risk of developing complications from the stones. <ul><li>Prophylactic cholecystectomy in asymptomatic gallstone disease may be considered for people with a partially calcified 'porcelain' gallbladder. </li></ul></li></ul></li><li><strong>For a person with asymptomatic gallstones found in the common bile duct.</strong><ul><li>Offer referral for bile duct clearance and laparoscopic cholecystectomy — although they are asymptomatic, there is a significant risk of developing serious complications such as cholangitis or pancreatitis. </li></ul></li></ul><!-- end field 40d6d47f-407e-4d86-823e-0c70c062ac65 --><!-- end item fc311a4a-7674-4853-8ac6-d6b9152c118c -->","subChapters":[{"id":"e3edf38c-b281-5741-b171-d2f0a6d3f6f3","slug":"basis-for-recommendation-58f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c6170087-411c-4eba-9098-b05d95bd202a --><h4>Basis for recommendation</h4><!-- end field c6170087-411c-4eba-9098-b05d95bd202a -->","summary":null,"htmlStringContent":"<!-- begin item 58f92dd4-c66b-4439-9b85-4c506c25a86b --><!-- begin field 9b400035-2760-409f-b7e1-c15316aa728f --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guideline <em>Gallstone disease</em>: <em>diagnosis and management of cholelithiasis, cholecystitis and choledocholithiasis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">NICE, 2014</a>] and the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) <em>Commissioning guide: gallstone disease </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">AUGIS, 2016</a>], the British Medical Journal (BMJ) best practice guide <em>Cholelithiasis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">BMJ, 2018</a>] and the European Association for the Study of the Liver (EASL) <em>EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">European Association for the Study of the Liver, 2016</a>].</p><h5>Referral for asymptomatic bile duct stones</h5><ul><li>All common bile duct stones should be referred for consideration of treatment because of the risk of potential severe complications [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">AUGIS, 2016</a>]. </li></ul><h5>Prophylactic treatment of asymptomatic people </h5><ul><li>There is currently no way of predicting which people will go on to develop complications. The NICE guideline development group (GDG) agreed that most people with asymptomatic gallbladder stones will not develop complications and felt that the prophylactic treatment of asymptomatic gallstones was likely to have a higher risk than leaving them untreated as all of the treatment options carry risks of adverse effects [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">NICE, 2014</a>]. <ul><li>EASL advises that an exception is asymptomatic people with porcelain gallbladder who may undergo cholecystectomy, as a relatively high percentage of people develop gallbladder carcinoma without prophylactic cholecystectomy — in some studies, porcelain gallbladder mainly diagnosed on abdominal X-ray, carcinomas were found in up to 20% of all calcified gallbladders. However, a causative relationship between porcelain gallbladder and gallbladder cancer has not been established [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">European Association for the Study of the Liver, 2016</a>]. </li><li>Ursodeoxycholic acid has limited value for dissolving established gallstones because of limited success and a high recurrence rate [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">BMJ, 2018</a>]. Evidence from randomised controlled trials, systematic reviews, and cohort studies show that ursodeoxycholic acid has a low rate of cure with only 27% of people having dissolution of stones after treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">Gurusamy, 2014</a>]. <ul><li>However, it may be useful in primary prevention of gallstones in high-risk groups, such as obese people undergoing rapid weight loss through dietary caloric restriction or bariatric surgery [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">European Association for the Study of the Liver, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/gallstones/references/\">BMJ, 2018</a>].  </li></ul></li></ul></li></ul><!-- end field 9b400035-2760-409f-b7e1-c15316aa728f --><!-- end item 58f92dd4-c66b-4439-9b85-4c506c25a86b -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}